文献速递妇科

宫颈癌微创根治性子宫切除术与开腹手术相比并发症更少且生存结局相似

Minimally Invasive Radical Hysterectomy for Cervical Cancer Is Associated With Reduced Morbidity and Similar Survival Outcomes Compared With Laparotomy.
PubMed 文献 · J Minim Invasive Gynecol · 2016-12-21

本研究为回顾性队列研究,纳入2000至2013年间在美国两家学术医疗机构接受初次根治性子宫切除术的宫颈癌患者383例,其中微创组101例、开腹组282例。结果显示两组总生存无差异,微创组估计失血量更少、输血率更低、住院时间更短,而复发率、淋巴结切除率及阳性率、切缘阳性率无差异。

要点

  • 微创组与开腹组总生存无差异(中位未达到;p=0.29)。
  • 微创组估计失血量中位数50 cm³ vs 开腹组500 cm³,输血率3.0% vs 26.2%(p<.001)。
  • 微创组住院时间1.9天 vs 开腹组4.9天(p<.001),并发症总发生率无差异(15.1% vs 17.2%;p=.87)。

核心结论

  • 微创根治性子宫切除术不损害患者结局,包括总生存、复发率、盆腔淋巴结切除频率或阳性率。
  • 微创组并发症减少,包括估计失血量减少、输血减少和住院时间缩短。

研究设计与样本

  • 回顾性队列研究(加拿大工作组分类II-1),在美国两家学术医疗机构进行,纳入2000年至2013年间接受初次根治性子宫切除术的宫颈癌女性。
  • 共383例符合条件,其中101例接受微创手术(传统腹腔镜、单孔腹腔镜或机器人),282例接受开腹手术。

主要发现

  • 总生存两组无差异(中位未达到;p=.29)。
  • 复发罕见且两组相当,微创组5.0% vs 开腹组6.4%(p=.86)。
  • 盆腔淋巴结切除率微创组98% vs 开腹组97%(p>.99),阳性率分别为10.9% vs 8.5%(p=.55)。
  • 盆腔淋巴结获取平均数微创组高于开腹组(19.4 vs 16.0;p<.001)。
  • 术后化疗率(p=.32)或放疗率(p=.28)两组无差异;切缘阳性率微创组5.0% vs 开腹组4.6%(p=.54)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To assess outcomes of women with cervical cancer undergoing upfront radical hysterectomy (RH) via a minimally invasive surgery (MIS) or a traditional laparotomy (XL) approach at 2 large US academic institutions to determine whether the mode of surgery affects patient outcomes. DESIGN: Retrospective cohort study (Canadian Task Force classification II-1). SETTING: Two academic medical institutions in the United States. PATIENTS: Women undergoing upfront RH for cervical cancer between 2000 and 2013. INTERVENTION: Minimally invasive techniques (laparoscopic and robotic) for RH compared with XL. MEASUREMENTS AND MAIN RESULTS: A total of 383 women met the eligibility requirements. Of these, 101 underwent an MIS (i.e., traditional laparoscopy, laparoendoscopic single site, or robotic) approach, and 282 underwent an XL approach. Overall survival (median not reached; p = .29) was not different between the 2 groups. Recurrence was rare and equivalent in the 2 groups, affecting 5.0% of patients in the MIS group and 6.4% of those in the XL group (p = .86). Pelvic lymph nodes were dissected in 98% of patients in the MIS group and 97% of those in the XL group (p > .99) and were found to be positive in 10.9% and 8.5% of those patients, respectively (p = .55). The mean number of pelvic lymph nodes retrieved was higher in the MIS group (19.4 vs 16.0; p < .001). There was no between-group difference in the rate of postoperative chemotherapy (p = .32) or radiation therapy (p = .28). Surgical margins were positive in 5.0% of specimens in the MIS group and in 4.6% of specimens in the XL group (p = .54). Although there was no difference in the overall rate of complications (15.1% and 17.2%, respectively; p = .87), laparotomy was associated with a higher median estimated blood loss (EBL) (50 cm3 vs 500 cm3) and a higher rate of perioperative blood transfusion (3.0% vs 26.2%; p < .001). Length of perioperative hospital stay was significantly shorter in the MIS group (1.9 days vs 4.9 days; p < .001). CONCLUSION: MIS RH does not compromise patient outcomes, including overall survival, rate of recurrence, and the frequency of pelvic lymph node dissection or positivity. Morbidity was decreased in the MIS group, including decreased EBL, fewer blood transfusions, and shorter hospital stay.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Diver E, Hinchcliff E, Gockley A, et al. Minimally Invasive Radical Hysterectomy for Cervical Cancer Is Associated With Reduced Morbidity and Similar Survival Outcomes Compared With Laparotomy. J Minim Invasive Gynecol. 2016. PMID: 28011096. doi:10.1016/j.jmig.2016.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。